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Abstract. Actin interacts with a large number of 
different proteins that modulate its assembly and medi- 
ate its functions.  One such protein is the yeast actin- 
binding protein Sac6p, which is homologous to ver- 
tebrate fimbrin (Adams, A. E.  M., D.  Botstein, and 
D.  G.  Drubin.  1991. Nature  (Lond.).  354:404--408.). 
Sac6p was originally identified both genetically 
(Adams, A.  E.  M., and D. Botstein.  1989.  Genetics. 
121:675-683.) by dominant,  reciprocal suppression of 
a temperature-sensitive yeast actin mutation (act1-1), 
as well as biochemically (Drubin,  D.  G., K. G. 
Miller,  and D.  Botstein.  1988. J.  Cell Biol.  107: 
2551-2561.).  To identify the region on actin that 
interacts with Sac6p, we have analyzed eight different 
act1 mutations that show suppression with sac6 mu- 
tant alleles, and have asked whether (a) these muta- 
tions occur in a  small defined region on the crystal 
structure of actin;  and (b) the mutant actins are defec- 
tive in their interaction with Sac6p in vitro. Sequence 
analysis indicates that all of these mutations change 
residues that cluster in the small domain of the actin 
crystal structure,  suggesting that this region is an im- 
portant part of the Sac6p-binding domain.  Biochemi- 
cal analysis reveals defects in the ability of several of 
the mutant actins to bind Sac6p, and a reduction in 
Sac6p-induced cross-linking of mutant actin filaments. 
Together,  these observations identify a likely site of in- 
teraction of fimbrin on actin. 
T 
HE actin cytoskeleton is a fundamental  component of 
eukaryotic cells, with widely divergent  roles within 
individual cells and among different cell types. For ex- 
ample,  even within a single cell, actin may be important in 
cell locomotion, the intracellular  movement of organelles, 
the structural integrity of the cell, and cytokinesis. For some 
of its functions,  actin is found as a stable array of filaments, 
whereas for others,  it is present in a highly dynamic state. 
Actin can exist in the cell as either monomers or filaments, 
and the filaments  themselves can vary enormously in both 
length and degree of cross-linking.  Such different assembly 
states and the changes  between them must be very tightly 
controlled both temporally and spatially, but the mechanisms 
by which these processes are both mediated and regulated re- 
main poorly understood. 
A large number of proteins that can affect the assembly 
state of actin in vitro have been identified, and it is likely that 
many of these also affect the assembly state and distribution 
of actin in vivo. Many of these proteins have been well char- 
acterized biochemically,  but in general, it has been difficult 
to  determine  which of the various biochemical activities 
have biological significance,  what the roles of these proteins 
are in the cell,  and how the various proteins function to- 
gether in vivo. We and others have applied genetic methods 
to this problem. In particular,  we have used yeast as a system 
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to identify actin-binding  proteins both genetically  and bio- 
chemically, make mutations in the genes encoding these pro- 
teins,  and then study the effects of these mutations both in 
vivo and in vitro. 
One such actin-hinding protein is the yeast homolog of the 
actin-filament  cross-linking  protein fimbrin  (Adams et al., 
1991), which is encoded by the SAC6 gene. SAC6 was origi- 
nally identified both biochemically on actin affinity columns 
(Drubin et al., 1988; Adams et al., 1989), as well as geneti- 
cally by dominant, allele-specific suppression of the tempera- 
ture-sensitive  ('Is) ~ act1-3 mutation  (Adams  and Botstein, 
1989).  Further genetic analysis  showed that suppression  is 
reciprocal i.e., that not only do the sac6 mutations suppress 
the act1-3 mutation, but also actl mutations suppress tem- 
perature-sensitive  sac6 mutant alleles.  The observation of 
allele-specific  and reciprocal suppression between various 
act1 and sac6 mutations (Adams and Botstein,  1989) pro- 
vides strong genetic evidence for a physical interaction  be- 
tween actin and the SAC6 protein, Sac6p. Indeed, the physi- 
cal association of Sac6p with actin has been demonstrated 
by its ability to bind to an F-actin  affinity column (Drubin 
et al.,  1988),  its ability  to bundle actin  filaments  in vitro 
(Adams et al., 1991), and by its colocalization  with actin in 
vivo (Drubin et al., 1988). The deduced sequence of Sac6p, 
which indicates it is a member of the fimbrin family of actin- 
bundling proteins (Adams et al., 1991), provides further sup- 
1. Abbreviation used in this paper: Ts, temperature sensitive. 
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protein. 
To  fully understand  the interaction  between actin  and 
Sac6p, it is necessary to identify the sites on actin that bind 
Sac6p. This analysis is greatly facilitated by the fact that the 
crystal structure of actin has been solved (Kabsch  et al., 
1990). We expected that mutations in actin that suppress (or 
are  suppressed  by)  mutations  in  SAC6 might  define  the 
Sac6p-binding  site of actin,  and in particular  (a) would all 
change  residues that lie in a discrete physical  locus in the 
three-dimensional  structure of actin; and (b) would interfere 
directly with Sac6p-actin binding, and hence Sac6p-induced 
cross-linking  of actin filaments in vitro.  We have therefore 
examined eight different act1 mutations that show suppres- 
sion with sac6 mutations.  We show that all of these muta- 
tions change residues that lie in a small region of the actin 
surface, and that some of these mutations result in defects in 
the binding of Sac6p to (and the subsequent Sac6p-induced 
cross-linking  of)  actin  filaments.  These  results  therefore 
define a likely binding site for Sac6p on actin,  and have im- 
portant implications  for understanding  the interaction  be- 
tween actin and Sac6p. 
Materials and Methods 
Yeast Strains and Media 
The yeast strains used in this study are listed in Table I. Media for yeast 
growth were as described previously  (Sherman et ai., 1974), except that in 
the growth of yeast cultures for actin preparation, the media yeast extract- 
Bacto-peptide contained 4% dextrose. 
Chemicals 
DNase I from bovine pancreas (grade ID and ATP (crystallized  disodinm 
Table I.  Yeast Strains Used in This Study 
salt, special quality) were obtained from Boehringer Mannheim Biochemi- 
cals (Indianapolis,  IN). DTT (molecular biology grade), formamide,  and 
protease inhibitors were obtained from Sigma Chemical Co.  (St.  Louis, 
MO). The formamide was deionized by use of a mixed bed resin (AG 501- 
XS; Bio Pad Laboratories, Richmond, CA) and stored in aliquots at -70°C. 
Isolation and Sequencing of  act1 Mutations 
Four act1 mutations (act/-7,  actl-8,  act1-9, and  actl-lO)  that had  been 
identified  as suppressors  of sac6-6 or sac6-7 (Adams and Botstein,  1989) 
were isolated from strains DBY5236, DBY5244, DBY5254, and DBY5241, 
respectively (Table 1). Genomic DNA was isolated from these strains by a 
modification of the method of Struhl et ai. (1979), the actin genes were am- 
plitied by PCR (Perkin-Elmer Cetus kit, Perkin-Elmer Cetus Instruments, 
Norwalk,  CT), and the PCR products were then sequenced  directly using 
a double-stranded DNA cycle sequencing  system (catalogue no. 8196SA; 
GIBCO BRL, Gaithersburg, MD) according to the manufacturer's instruc- 
tions, except that T-33p-labeled ATP (catalogue  no.  NEG302H; New En- 
gland Nuclear,  Boston, MA) was used instead of ~t-32p-labeled ATP. For 
each mutation, the entire coding region of the actin gene was sequenced to 
ensure that the mutations identified were the only changes in the sequence 
and, thus, were responsible for the phenotypes. 
Localizing the actl Mutations on the Structural 
Model of  Acffn 
The crystal structure of rabbit muscle actin in a 1:1 complex with DNAse 
I was described by Kabsch et ai. 0990). Recently, a refined strucaae of the 
actin filament has been described by Lorenz et ai. (1993), and the atomic 
coordinates of the F-actin monomer were kindly made available to us by 
M.  Lorenz (Max-Planck Instltut fur Modizinische Forschung  Abteilung 
Biophysik,  Heidelberg,  Germany). These latter coordinates were used to 
display the actln models shown in Fig. 1. lma~ of the actln monomvr were 
generated using an IRIS Indigo XZ 4000 workstation (Silicon Graphics 
Computer Systems, Mountain View, CA) using the Viewer module of the 
Insight I1 program (Biosym Technologies,  San Diego, CA). Since the pri- 
mary sequences of rabbit muscle and yeast actins are 87% identical  and 
92 % similar overall,  it is likely that the three-d~ensional structures of 
these two proteins will prove to be nearly identical (Chothia and Lesk, 
1986). All of the residues affected by the mutations described in this study 
are identical between these two molecules, and they lie in a region of the 
Strain  Genotype  Sourec/reference 
AAYI021*  MATa actl-3 tub2-201  sac6-2 ura3  This study 
AAY1111"  MATa actl-3 sac6-5 his4-619  This study 
AAY1115"  MATt~ actl-3 sac6-15 his4-619  This study 
AAY1643*  MATa actl-2 sac6-2 his4  This study 
AAY1644~  MA Ta act  l- 7 ura3  This study 
AAY1645~  MATa actl-8 leu2  This study 
AAY1646~  MATa actl-9  This study 
BJ562811  MATa/MATa ura3/ura3 trp l / + 
his3/his3 pep4::HIS3/pep4::HIS3 
prbl/prbl  canl/canl  leu2/ +Gal  + 
MATa his4 
MATa sac6-6 actl-7 ura3-52 
MATa sac6-6 actl-lO ura3-52 
MATa sac6-6 actl-8 ura3-52 
MATa sac6-7 actl-9 ura3-52 
MATa actl-120: :HIS3 canl ade4 
his3 leu2 ura3 tub2-201  cryl ? 
MATa actl-125::HIS3  canl ade2 
his3 leu2 ura3 tub2-201 
DBY877 
DBY5236 
DBY5241 
DBY5244 
DBY5254 
KWY361¶ 
KWY3761 
Jones (1991) 
Adams and Botstein (1989) 
Adams and Botstein (1989) 
Adams and Botstein (1989) 
Adams and Botstein (1989) 
Adams and Botstein (1989) 
Ken Wertman 
Ken Wertman 
* These strains are segregants from the original diploid actl-3/actl-3  sac6/+  revenaats described in Adams and Botstein (1989). 
AAY1643 was a Ts+ (therefore sac6-2)TUB2+ (therefore assumed to carry the tightly linked actl-2  mutation) segregant obtained from a cross of AAYI021 
to DBY1991 (MATa actl-2  TUB2+ his4-619; Adams and Botstein, 1989). 
§ AAY1644, AAY1645, and AAY1646 are Ts segregants derived from crosses of DBY2059 or DBY2060 (Adams and Botstein, 1989) to DBY5236, DBY5244, 
and DBY5254 (Adams and Botstein, 1989), respectively. 
14 BI5628 was obtained from the Yeast Genetics Stock Center (Donner Laboratory, University of California at Berkeley). These strains were obtained from K. 
Wertman (Selectide Corp.,  Oro Valley, AZ). 
¶ The actl alleles in these strains are described in Wertman et al. (1992). 
The Journal of Cell Biology, Volume 126, 1994  414 Figure 1. Location in a model of rabbit muscle actin of residues corresponding to those changed by the yeast act1 suppressor mutations. 
A model of the rabbit muscle actin molecule was displayed from the atomic coordinates of the rabbit muscle actin as determined by Lorenz 
et al. (1993). (A) A space-filling model of the actin molecule (excluding the hydrogen atoms) is shown in approximately the same orientation 
as seen in Fig.  1 in the original actin crystal structure paper (Holmes et al.,  1990).  The residues corresponding to the mutations in yeast 
actin that suppress or are suppressed by sac6 mutant alleles are indicated in black.  The residues that correspond to pepfides implicated 
by other studies (Mimura and Asano,  1987;  Lebart et al.,  1990,  1993; Levine et al.,  1992; M6jean et al.,  1992; Fabbrizio et al.,  1993) 
as binding to the conserved actin binding domain referred to in the text (see Discussion) are shaded grey (actin residues  1-12,  83-125, 
and 350-375).  (B) The actin molecule after a rotation of 90 ° from the orientation shown in Fig.  1 A. (C) A ribbon diagram of yeast actin 
in the same orientation as in Fig.  1 A. The amino acids affected by the suppressor mutations listed in Table 1I are represented as stick 
figures projecting from a ribbon describing the course of the polypeptide chain. The positions of the amino and carboxy termini of actin 
are also indicated (N and C, respectively). (D) Subdomains  1 and 2  (referred to in the text) of the actin monomer are shaded white and 
dark grey, respectively. These two subdomains constitute the %mall domain" of actin (see Kabsch et al., 1985). The suppressor mutations 
are shaded black as in Fig.  1 A. 
actin molecule that is highly conserved.  The amino acid residues changed 
by the suppressor  mutations  are highlighted in black in Fig.  1. 
Biochemical Purification of Yeast Actin 
Yeast actin  was  pun'fled  from  strains  AAY1021, AAYI643,  AAYI644, 
AAY1645, AAYI646, DBY877, DBY5241, KWY361, and KWY376 (Table 
I) by DNase I affinity chromatography  essentially as described by Kronet 
ai. (1992), but incorporating modifications described by Cook and Ruben- 
stein 0992) and the additional changes noted below. Details of the purifica- 
tion will be provided by the authors upon request. 
Subsequent to elution from the DNase I column, actin was eluted from 
a column (DE-52); Wl~tman Chemical Separation Inc., Clifton, NJ) as de- 
scribed by Cook and Rubenstein (1992), except that the elution used a step 
gradient of  column buffer containing 50, 100, 200, and 300 mM KC1 instead 
of a single 300-raM  step. In most purifications,  the majority  of the actin 
Honts et al. Fimbrin-binding Site on Actin  415 eluted with 200 mM KC1, and only this fraction was processed further. 
However, in the case of the actl-120 strain (E99A, E100A), most of the actin 
eluted at 100 mM KCI. 
The actin-enriched fractions from the DE-52 elution were dialyzed at 
room temperature for several hours against 2.0 liters of F-actln buffer (50 
mM Hepes-K  +, pH 7.5, 50 mM KCI, 0.2 mM ATP, 0.2 mM CaCI2, 5 mM 
MgC12, and 0.5 mM DTT) to reduce the concentration  of KCl to ~50 mM. 
This step appeared to ensure the maximal recovery of the actin filaments, 
especially  in the case of some of the mutant actins, which appeared to as- 
semble poorly in elevated  salt concentrations. 
Finally,  the F-actin was pelleted, depolymerized by dialysis (against 5 
mM Hepes-K +, pH 7.5, 0.2 mM ATE 0.2 mM CaCI2, 0.5 mM DTT, plus 
protease inhibitors at final concentrations of 1 /tg m1-1 for cbymostatin, 
popstatin, leupeptin, antipaln, and 1 mM for PMSF),  and the resulting 
G-actin solution was clarified  essentially  as described previously.  The su- 
pernatant was  recovered,  and a  Bradford's dye  binding assay  (BioRad 
Laboratories) was used to estimate the protein concentration. If  the protein 
concentration was ~0.5 nag m1-1, the clarified G-actin solution was rapidly 
frozen as small aliquots (30-50 ;tl) in liquid nitrogen and stored at -70°C 
until used in the binding and cross-linking assays described below. Clarified 
dlalysates  with protein concentrations <0.5 nag ml  -I usually indicated a 
failure to purify actin, and they were not processed further. 
There were no obvious contaminating  proteins or proteolytic fragments, 
as judged by SDS gel electrophoresis at the loadings (1.6/~g of actin) used 
for binding and cross-linking assays (Fig. 2). When greater amounts of actin 
were loaded (>I0 ~,g/lane), several faint  bands could be seen below the sin- 
gle major band at 43 kD. We presume, based on previous experiments,  that 
these bands are products of proteolytic degradation of actin. 
Biochemical Purification of  Sac6p 
Sac6p was purified  from strain BJ5628  (Table I) containing a plasmid ex- 
pressing Sac6p from the GALI-IO  promoter.  The details of this purification 
will be presented in a separate publication (Sandrock,  T., and A. Adams, 
manuscript in preparation). Briefly,  the cell lysate was  fractionated by 
DEAE chromatography,  ammonium sulfate precipitation, and hydmxylapa- 
rite chromatography to yield fractions highly enriched in Sac6p.  Elution 
from the hydroxylapatite column yielded two overlapping peaks, the first of 
which was used in all  experiments described in this paper.  Preliminary 
results suggest Sac6p from the second peak discriminates less web between 
wild-type and mutant actins in the binding and cru~s-linking assays.  The 
nature of the biochemical difference between the protein in the two peaks 
is currently under active investigation. 
Actin Filament Binding and Cross-linking Assays 
The concentrations of purified actin and Sac6p were estimated by using the 
Bradford dye binding assay, with gamma globulin at a known concentration 
serving as the protein standard. Binding and cross-linking assays were set 
up as I00-~1 reactions with actin at 3 pM and Sac6p at 0.3 #M, a molar 
ratio that had been shown by electron microscopy  to produce actin bundles 
with wild-type yeast actin and Sac6p (Adams et al.,  1991). 
Immediately before use, frozen aliquots of G-actin were rapidly thawed 
and clarified by centrifugation at 70,000 rpm (190,000 g) for 30 rain at 4°C 
in a TLA-100 rotor (Beckman Instruments, Palo Alto, CA) to remove in- 
soluble aggregates.  Purified Sac6p, which had been diluted in depolymer- 
ization buffer, was clarified  in the same manner before use.  The clarified 
protein solutions were kept on ice and were promptly used in the assays de- 
scribed below. 
Binding assays were performed by adding actin to freshly made depoly- 
merization buffer (with the protease inhibitors), followed by the addition of 
Sac6p.  Finully, polymerization was initiated by the addition of 20x poly- 
merization buffer (450 mM Hepes-K  +, pH 7.5, 20 mM EGTA,  500 mM 
KCI,  and 80 mM MgCl2),  and the mixture was  gently pipetted up and 
down.  These mixtures were then incubated at 22°C for 90 min. After this 
time, a 25-/~1 sample was withdrawn from the mixture,  and mixed with an 
Figure 2. Actin-binding and cross-linking assays for wild-type and mutant actins paired with wild-type Sac6p,  SDS-PAGE of supernatants 
(S) or pellets (P) obtained by high speed (HS) or low speed (LS) centrifugation of wild-type or mutant actins polymerized in the presence 
(+) or absence (-) of Sac6p,  as described in Methods.  The positions of yeast actin (A) and yeast fanbrin (F) protein bands in the gels 
are indicated. The proteins were resolved in a 10% SDS-polyacrylamide gel and stained with Coomassie blue R-250. The data are represen- 
tative of at least two separate  experiments. 
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then centrifuged at 190,000 g in a TLA-100 rotor at 22"C for 30 mill. Under 
these conditions, almost all wild-type actin sediments, whether or not Sac6p 
is present (Fig. 2). However, under nonpolymerizing conditions, essentially 
no actin sediments (not shown). ARer centrifugation, a 25-td sample of the 
supernatant was withdrawn from the meniscus and mixed with an equal vol- 
ume of 2X gel sample buffer.  The remainder of the supernatant was care- 
fully removed and discarded, and the remaining pellet (usually not visible) 
was solubllized with 150/d of 1× gel sample buffer. Thus, the total mixture, 
the high speed supernatant, and the high speed pellet were all solubilized 
in gel sample buffer at the same relative concentration. The protein samples 
were boiled for 5 rain, separated by SDS-PAGE (25/zl sample/lane), and 
then stained with Coomassie blue. 
The eross-linkin~ assays were performed in a similar mamler, e~tcept that 
the mixtures were centrifuged in a TLA-100 rotor at 12,000 rpm (6,000 g) 
for 15 rain at 22"C instead of 190,000  g for 30 rain at 220C.  This degree 
of centrifugation was  sufficient to pellet almost all wild-type acfin and 
Sac6p, when the two were mixed in this assay, but it was insufficient  to sedi- 
ment most wild-type aetin in the absence of Sae6p (Fig. 2). These assays 
do  not  distinguish between cross-linked filaments and  nonspeeilic ag- 
gregates, but because the actin is found in the low speed pellet in the pres- 
ence (but not the absence) of Sae6p (Fig. 2), we presume it is present as 
cross-linked filaments. In each experiment, control experiments without the 
addition of Sactp were conducted in parallel to assess the self-aggregation 
ability of actin filaments. 
These experiments were performed at 22"C, rather than at 37"C (the re- 
strictive temperature of most of the act/mutants) because our preliminary 
observations indicated that even wild-type actin was poorly cross-linked by 
Sac6p at 37"C. The use of 220C for these experiments is validated by the 
fact that some of the act/mutants grow poorly (and thus have defective ac- 
tin) even at 220C,  and all of the act/mutant actins analyzed biochemically 
in this study can suppress the sac6 temperature-sensitive defects (and thus 
show altered interactions with mutant Sac6p) at this temperature (Table II, 
legend). 
Electron Microscopy 
Samples prepared in the cross-linking assays described above were also used 
for electron microscopy. Aliquots were removed from the mixtures before 
centrifugation, and they were immediately negatively stained with 2 % ura- 
nyl acetate. Using a JEOL 100cx or Hitachi 500 microscope, wild-type mu- 
tant filaments were scored by an observer unaware of their identity for abil- 
ity to be bundled in the presence or absence of Sae6p. 
Results 
The goal of these experiments was to test the hypothesis that 
act1 mutations that suppress or are suppressed by sac6muta- 
tions  identify the  Sac6p-binding  domain  on  actin.  Two 
predictions of this hypothesis were: (a) that the act1 muta- 
tions would fall into a small region of the actin molecule, the 
likely Sac6p-binding site; and (/7) that biochemical experi- 
ments with actin and Sac6p would reveal a direct defect in 
the  interaction between  these  two proteins.  Experiments 
were therefore conducted to test these predictions. 
Identification of  Additional act1 Mutations that Show 
Suppression with sac6 Mutants 
We wished to analyze as large a collection as possible ofactl 
mutations that suppress or can be suppressed by sac6 mutant 
alleles. We already had at hand six act1 alleles (actl-2, actl- 
3, act1-7, actl-8, act1-9,  and actl-lO;  see Table H) that sup- 
pressed sac6 mutations, but to further increase the pool, we 
examined a set of eight temperature-sensitive act1 mutations 
generated by alanine-scanning mutagenesis (Wertman et al., 
1992).  These eight mutations were chosen from the larger 
collection of such mutants as those that showed the tightest 
temperature-sensitive growth defects at restrictive tempera- 
ture, as well as reasonably good growth at permissive tem- 
perature (Wermmn et al.,  1992). 
We first tested whether any of the eight actl mutations 
could be suppressed by any one of seven different sac6 mu- 
tant alleles isolated previously as dominant suppressors of 
actl-3.  Thus,  temperature-sensitive  ura3  strains  carrying 
act1-105, act1-108, act1-112, act1-119, act1-120, act1-125, act1- 
132, or actl-133  (Wertman et al.,  1992)  were transformed 
with centromere-containing plasmid carrying the selectable 
marker URA3 and either wild-type SAC6 or one of the sup- 
pressor mutations sac6-4, sac6-5,  sac6-7, sac6-14, sac6-15, 
sac6-17, or sac6-19.  Ura  + transformants were selected and 
tested  for temperature  sensitivity.  Two act1  alleles  were 
found to be suppressed by at least some sac6alleles: act1-120 
was consistently and strongly suppressed by all seven sac6 
alleles tested,  and act1-125 was consistently (though less 
strongly) suppressed by plasmids carrying sac6-4, sac6-5, or 
sac6-15. Interestingly, even the centromere-containing plas- 
mid carrying wild-type SAC6 showed some suppression of 
actl-125,  suggesting the defect in act1-125 is caused by re- 
duced affinity for Sac6p,  and can also be suppressed by in- 
creased levels of wild-type Sac6 protein. None of the other 
actl mutants were consistently suppressed by any of  the sac6 
Table II.  Temperature Sensitivity and Sequence Changes of actl Mutations* 
act1 SAC6  +  Residue 
actl allele  Ts- or Ts+  changed  Subdomain~ "  Reference 
actl-2  Ts-  A58T  2  Shortle et al.  (1984) 
act1-3  Ts-  P32L  1  Shortle et al.  (1984) 
act1-7  Ts-  K61N  2  Adams and Botstein (1989) 
act1-8  Ts-  H88Y  1  Adams and Botstein (1989) 
act1-9  Ts-  D56A§  2  Adams and Botstein (1989) 
actl-lO  Ts+  T89I  1  Adams and Botstein (1989) 
act1-120  Ts-  E99A,E100A  1  Wertman et al.  (1992) 
act1-125  Ts-  K50A,D51A  2  Wertman et al.  (1992) 
The actl mutant alleles listed all suppress sac6 mutations,  and in all cases where the act1 mutation is Ts in a SAC6+ genetic background  (see table above),  they 
are also suppressed by sac6 mutant alleles. 
* The temperature-sensitive phenotypes and sequences of act1-2, act1-3, act1-120, and act1-125 have been reported previously (Shortie et al.,  1984; Wertman 
et al., 1992). The phenotypes of the act1-7, act1-8, act1-9, and actl-lO mutants were described previously  (Adams and Botstein,  1989); the sequences of these 
latter four mutations  were determined in this study (see text). 
Subdomains  refer to the nomenclature  of Kabsch et al. (1990). 
0 The sequence of act1-9 (D56A) reveals that this mutation is very similar to that of act1-124 (D56A, E57A), described by Wertman et al. (1992). The suppressi- 
bility of act1-124 by sac6 mutations  has not been tested. 
Honts et al. Fimbrin-binding Site on Actin  417 Figure 3.  Electron microscopy of actin filaments in the absence and presence of Sac6p. Samples of the bundling assays were examined 
by negative staining using electron microscopy. The reaction conditions are described in Materials and Methods. (,4 and B) Wild-type 
actin filaments in the absence (A) and in the presence (B) of Sac6p. Most of the aetin filaments appear to be found in bundles in the presence 
of Sac6p. (C and D) act1-7  actin filaments in the absence (C) and presence (D) of Sac6p. act1-7  filaments are clearly defective in the forma- 
tion of  bundles when compared to wild-type  actin; instead, many single filaments are visible. (E and F) acd-9 actin filaments in the absence 
(E) and presence (F) of Sac6p. Bundle-like aggregates of act1-9 filaments are observed even in the absence of Sac6p, but the bundles seen 
in the presence of Sac6p appear more similar to wild type. 
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be noted that if any of  the sac6 mutations were recessive sup- 
pressors of these actl alleles, however, they would not have 
shown suppression in this analysis.) This analysis therefore 
succeeded in identifying two actl alleles (actl-120 and actl- 
125)  that  can  be  suppressed  by  sac6 mutant  alleles  on 
plasmids. 
Tetrad analysis was used to ensure that the observed sup- 
pression of actl-120 and actl-125 by sac6 mutant alleles oc- 
curred not only when the sac6 mutations were present on 
plasmids, but also when they were in the genome. Thus, in 
crosses between KWY361  (actl-120 SAC6  +) and AAYlll5 
(actl-3  sact-15),  and between KWY376  (actl-125 SAC6  ÷) 
and AAYll 11 (actI-3 sact-5), temperature sensitivity segre- 
gated 2:2, confirming that actl-120 is suppressed by sac6-15, 
and actl-125 is suppressed by sac6-5 (data not shown). For 
the purposes of this study, we were interested in identifying 
actl mutations that could be suppressed by at least one sac6 
allele, rather than in identifying the spectrum of sac6 muta- 
tions that could or could not suppress the various actl alleles. 
Lack of suppression is less meaningful than suppression it- 
self because it is likely that suppression depends greatly on 
the nature of the mutational change and, therefore, that many 
possible amino acid substitutions at a particular residue will 
not cause suppression. Therefore, as actl-I20 and actl-125 
can both be suppressed by at least one sac6 mutant allele, 
these mutations were added to the collection of mutants to 
be analyzed further, giving a total of eight (Table II). 
Isolation and Sequencing of  act1 Mutations 
Four of the eight actl mutations that suppress or are sup- 
pressed by sac6 mutant alleles (i.e., act1-2, act1-3, actl-120, 
and act1-125) had already been sequenced (Shortle et al., 
1984; Wertman et al., 1992); the changes are listed in Table 
II. The remaining four mutations (act1-7, actl-8, act1-9, or 
actl-lO) had not yet been sequenced,  and were therefore 
isolated and analyzed. Genomic DNA was prepared from 
strains carrying these mutations (Materials and Methods), 
the mutant actin genes were amplified by PCR, and the actl 
mutations were identified by sequencing. In each of these 
four cases, the mutations identified (Table II) were shown 
to be  the only changes  in  the  entire actl  sequence (see 
Materials and Methods), and thus were responsible for the 
suppression phenotype. 
Location of  Actin Mutations in a Model of  Actin 
The eight act1 mutations that show suppression with sac6 al- 
leles are found widely distributed in the primary structure 
of actin, from residues 32-99/100  (Table II). If these actl 
mutations occur in the Sac6p-binding domain on actin, we 
predict that in the three-dimensional structure of actin the 
mutations might occur in a small region, rather than be scat- 
tered over the surface of the molecule. Because of the highly 
conserved nature of actin (see Materials and Methods), it is 
possible  to  identify the  relative positions of the  affected 
residues in the three-dimensional structure of either the rab- 
bit or yeast actin molecules with a high degree of confidence. 
The molecular model of rabbit actin was used for Fig.  1. 
Strikingly, the eight actin mutations in Table I1 all change 
residues in one region of the "small domain" (Kabsch et al., 
1985) of actin. According to the nomenclature of Kabsch et 
al. (1990),  the small domain is comprised of subdomain 1 
(residues  1-32,  70-144,  and 338-375)  and subdomain 2 
(residues 33-69) (see Fig. 1 D). It can be seen in Fig. 1 that 
all of these mutations are relatively near to one another, and 
they localize either to subdomain 2 or to the part of subdo- 
main 1 adjacent to subdomain 2 (Fig. 1 D). This clustering 
of mutant residues suggests that Sac6p binds to this region 
of the actin molecule; consistent with this idea, most muta- 
tions that are not suppressed by sac6 mutations are located 
elsewhere in the molecule (not shown). 
Biochemical Analysis of Valid-type and Mutant 
Actin and Sac@ 
The finding that all the actin mutations that show suppression 
with sac6 mutations alter residues in a relatively small re- 
gion of the actin crystal structure suggested that this region 
of  actin forms at least part of  the Sactp-binding domain. This 
led to the strong prediction that the mutant actins would be 
defective in their interactions with Sac6p, under conditions 
in which these were the only two proteins present. We there- 
fore tested the ability of wild-type Sactp to bind to and 
cross-link actin filaments in vitro, using purified Sactp and 
actin. 
Since both the Sac6p-binding and Sac6p-induced cross- 
linking assays depended on the ability of the mutant actins 
to polymerize, it was first necessary to show that polymer- 
ization was not grossly affected by the changes. Indeed, all 
of the mutant actins were able to undergo polymerization, 
as judged by increases in viscosity, ability to sediment during 
high speed centrifugation (Fig. 2), and electron microscopy 
of mutant filaments (e.g., Fig. 3).  It was therefore possible 
to analyze all of the mutant actins in the Sac6p-binding and 
Sac6p-induced cross-linking experiments described below. 
Binding of  Sactp to actin filaments was assessed by mixing 
actin and Sac6p, initiating the assembly of actin filaments, 
and recovering the  filaments (either  individual or  cross- 
linked)  by  high  speed  centrifugation (see  Materials  and 
Methods).  Samples of the mix before centrifugation (not 
shown), the supernatant after centrifugation, and the result- 
ing pellet were  solubilized for  SDS-PAGE.  The  samples 
were adjusted to the same relative concentrations and sepa- 
rated in gels (Fig. 2). Defective binding of Sac6p to mutant 
actin would be expected to result in an increase in the amount 
of Sactp remaining in the supernatant. 
Cross-linking of actin filaments by Sac6p was tested simi- 
larly, except that cross-linked actin filaments, which sedi- 
ment more rapidly than individual actin filaments, were re- 
covered by low speed rather than high speed centrifugation. 
Under these conditions, the majority of individual filaments 
do not sediment (see below). Defective cross-linking of mu- 
tant actin by Sac6p would be expected to result in increased 
levels of both actin and Sac6p in the supernatant from the 
low speed centrifugation. 
When wild-type actin was used in these experiments, al- 
most all the actin and Sac6p was recovered in the high speed 
pellet (Fig.  2 A),  indicating that actin was present as in- 
dividual and/or cross-linked filaments to which Sac6p was 
bound. Since essentially all the actin and Sac6p was found 
in the low speed pellet also (Fig. 2 A), most of the actin in 
the assembly mix must be present as cross-linked structures, 
rather than individual filaments. This result is in contrast to 
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the actin remains in the low speed supernatant. 
When the various mutant actins were used in these assays, 
in each case, most of the actin was again found in the high 
speed pellet, and thus, like wild-type, was polymerization 
competent, as mentioned above.  However,  the amount of 
Sac6p that sedimented with the mutant actins varied. For ex- 
ample, in the case of actl-125, nearly all the Sac6p remained 
in the supernatant (Fig. 2 G), indicating that these filaments 
were drastically reduced in their ability to bind to Sac6p. In 
addition,  most of these actl-125 filaments were not sedi- 
merited by low speed centrifugation (Fig. 2  G), and thus 
were substantially less cross-linked than wild type. Similar 
defects in binding of Sac6p and ability to be cross-linked 
were observed for actl-120 (Holtzman et al., 1994; our un- 
published results). In the case of actl-7, about half of the 
Sac6p remained in the high speed supematant (Fig. 2 C), in- 
dicating that these actin filaments did not bind Sac6p as well 
as did wild type. In addition, these actl-7filaments were not 
well sedimented by low speed centrifugation (Fig. 2 C), and 
thus were not as extensively cross-linked as wild type. Con- 
sistent with these data, relative to wild type, actl-7and actl- 
125 actin filaments are defective in the formation of bundles 
as judged by electron microscopy (e.g., Fig. 3, B and D). 
Less extreme defects in binding and crosslinking activities 
of Sac6p were observed in experiments with act1-2, act1-8, 
and acd-lO filaments (Fig. 2, B, D, and F). For example, in 
the case of actl-8 (Fig. 2/9), most of the Sac6p was found 
in the high speed pellet with the actin, indicating little or no 
defect in the binding of Sactp to this mutant actin. Further- 
more, most actin and Sactp were also found in the low speed 
pellet, suggesting the mutant filaments were primarily cross- 
linked. 
Interestingly, we could not assess the ability of actl-9 actin 
filaments to be cross-linked because these mutant filaments 
were observed to undergo self-aggregation in the absence of 
Sac6p (Fig. 2 E), a result that was confirmed by electron mi- 
croscopic observations of act1-9 filaments in the absence of 
Sac6p (Fig. 3 E). 
Unlike the mutant actins described above,  actl-3  actin 
showed variable degrees of defects in ability to be cross- 
linked by Sac6p in several different  experiments (not shown), 
with the results ranging between those seen with actl-2 and 
actl-7 actins (Fig. 2, B and C, respectively). 
Discussion 
We report here the identification of a likely fimbrin-binding 
site on actin. This identification is based on two lines of evi- 
dence. First, eight out of  eight actin mutations that show sup- 
pression with mutant alleles of  yeast fimbrin (Sactp) all clus- 
ter in one region of the "small domain" of actin (Fig.  1 D). 
Second, several of these actl mutations have a direct effect 
on the interaction of actin with Sactp in vitro. 
Location of  actl Mutant Residues 
in the Actin Structure 
The act1 mutations that show suppression with sac6 mutant 
alleles all lie between residues 32 and 100, and they cluster 
in the small domain of actin (Fig. 1 D). This concentration 
of mutant residues in the three-dimensional structure sug- 
gests that this region of actin is likely to be an important part 
of the Sac6p-binding site. Genetic studies of Holtzman et al. 
(1994) involving an analysis of synthetic-lethal interactions 
support this notion. Consistent with this possibility, this re- 
gion is readily accessible in the filament model (Holmes et 
al.,  1990;  Milligan et al.,  1990;  Lorenz et al.,  1993),  and 
most of the actl mutations that fail to show suppression with 
sac6 mutant alleles are located elsewhere in the molecule 
(not shown). It should be noted, however, that the actl sup- 
pressor mutations described in this study all show suppres- 
sion with sac6 alleles that were originally isolated as sup- 
pressors of act/-3. Our results therefore do not rule out the 
possibility that Sac6p also binds to other sites on actin. It 
might be possible, for example, to isolate a class ofsac6mu- 
rations  that  show  suppression  with  act1 mutations  that 
change residues elsewhere on the surface of actin. However, 
in the synthetic-lethal analysis of Holtzman et al.  (1994), 
,,020 other actl mutations (that change residues all over the 
surface of actin) failed to show genetic interactions indica- 
tive of another Sactp-binding site. 
Defective Interactions of  Mutant Actins with Sac@ 
The hypothesis that the actl mutations analyzed in this study 
identify the Sactp-binding domain on actin is also supported 
by the finding that several of the mutant actins examined are 
defective in their interactions with wild-type Sac6p in vitro. 
In particular, actl-7, act1-120, and actl-125 actins show clear 
defects in their binding to (and subsequent cross-linking by) 
Sac6p, suggesting that the altered residues in the mutant pro- 
teins disrupt the normal interactions that occur between actin 
and Sac6p. For example, certain residues on actin and Saetp 
may normally interact with each other, but can be prevented 
from doing so by mutations that directly change these partic- 
ular residues. The actins most defective for binding to and 
cross-linking by Sactp (acd-7, act1-120, and acd-125) all in- 
volve mutations that result in the substitution of  polar or non- 
polar residues for the charged residues of the wild-type form 
(Table H). This may imply that the actin-Sac6p interaction 
has an important electrostatic component. 
Alternatively, the mutations may have more indirect ef- 
fects, such as by causing local changes in the structure of 
the actin molecule in the region of the binding site.  The 
actl-2 mutation, for example, may have such an effect be- 
cause it changes a residue that is believed to be buried in the 
actin molecule. The formal possibility that the mutations 
cause more global defects (e.g., in folding) in the whole actin 
monomer seems unlikely because the mutant actins are nor- 
mai by several other criteria, including (a) ability to bind to 
other monomers in polymerization (as judged by the forma- 
tion of a viscous solution upon addition of polymerization 
buffer and subsequent pelleting (Fig. 2), as well as by elec- 
tron microscopy of mutant actin filaments (e.g., Fig. 3); (b) 
ability to bind to DNAse I in the initial stages of  the purifica- 
tion (see Materials and Methods); and (c) at least in the case 
of actl-120, the mutant protein is still able to bind to cofilin 
(Holtzman et al.,  1994).  It therefore seems likely that the 
actl suppressor mutations identify a Sactp-binding site on 
the surface of actin. 
Comparison of  Defects of  Mutant Actin Filaments in 
Binding to (and Cross-linking by) Sactp 
Sac6p contains a tandem pair of imperfect repeats, both of 
which are homologous to the actin binding domains of sev- 
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is presumably like other monomeric fimbrins (Bretscher, 
1981; Glermey et al., 1981), which are assumed to use both 
actin-binding domains to cross-link adjacent actin filaments. 
It is not known whether each of the actin-binding domains 
in  fimbrin bind  to  the  same  or  different sites  on  actin 
monomers in  adjacent filaments.  The homology between 
these domains suggests that they might interact with actin in 
a similar way. However, there are precedents for structurally 
homologous domains binding to different sites on actin. For 
example, the two homologous domains of the aetin-bundling 
protein scruin are observed to bind to different subdomains 
of actin (Owen and DeRosier,  1993;  Schmid et al.,  1994). 
Our data do not provide us with information as to whether 
the two actin-binding domains of Sac6p bind to the same or 
different sites on actin because we do not know how many 
Sac6p  molecules  are  required  to  form an  actin  bundle, 
whether the interactions between actin and the two Sac6p 
domains are independent, or whether the two actin-binding 
domains are equivalent. For example, the finding that cross- 
linking is more defective that binding to Sac6p (e.g.,  for 
act1-7, and act1-125; see Fig. 2) could be explained by either 
model, i.e., that the two actin-binding domains bind to the 
same site or that they bind to different sites on actin. 
Comparison of the Putative Binding Sites on Actin for 
l~mbrin and Related Actin-binding Proteins 
Sac6p is a member of a group of actin cross-linking proteins 
including ot-actinin, ~-spectrin, filamin, dystrophin, fimbrin, 
and actin gelatin factor that share a homologous 27-kD actin- 
binding domain (Matsudaira, 1991). It might therefore be ex- 
pected that these proteins would all bind to the same region 
on actin. The fimbrins (including yeast Sactp) and closely 
related plastins possess a tandem repeat of this conserved 
actin-binding domain, but before this study, no information 
was available concerning the binding site for these proteins 
on the actin molecule. There have, however, been extensive 
studies of the binding site on actin for ot-actinin, filamin, and 
dystrophin, each of which has  a  single conserved 27-kD 
actin-binding domain (Mimura and Asano, 1987; Lebart et 
al.,  1990,  1993;  Levine et al.,  1992;  Mtjean et al.,  1992; 
Fabbrizio et al., 1993).  All of the peptide segments of actin 
implicated in binding to the conserved actin-binding domain 
in these studies are found within subdomain 1, and they are 
shown highlighted in gray in Fig. 1, A and B. These segments 
comprise residues  1-12 (NH2-terminus of actin),  residues 
83-125,  and residues 350-375  (COOH terminus of actin) 
(Mimura and Asano, 1987; Lebart et al., 1990, 1993; Levine 
et al.,  1992;  M~jean et al.,  1992;  Fabbrizio et al.,  1993). 
However, there is little evidence for an interaction of  the con- 
served actin-binding domain with actin in the regions en- 
compassed by the suppressor mutations. In particular, only 
three (act1-8, actl-lO, and act1-120, at residues 88,  89, and 
99/100, respectively) of the eight suppressor mutations lie in 
any of the regions defined biochemically, the other five caus- 
ing changes between residues 32 and 61 of actin. 
It  might  seem  from  these  comparisons  that  although 
o~-actin, filamin, dystrophin, and fimbrin share a conserved 
actin-binding domain by sequence comparisons, they do not 
all bind to the same region on actin. As mentioned above, 
there are precedents for homologous domains not binding to 
the same sites on actin. However, it is also possible that these 
proteins all bind to the same region on actin, and that two 
fundamentally different approaches have identified different 
regions of actin that bind to the conserved actin-binding do- 
main. In this case, it would be expected that biochemical ex- 
periments with actin and fimbrin, similar to those conducted 
for the other proteins and actin, would identify  the same sites 
of interaction. It may be, for example, that many mutations 
in the region identified biocbemically would be lethal, and 
thus not identified as suppressors. Or perhaps the residues 
identified by suppressor analysis interact more weakly with 
the conserved actin-binding domain than do those identified 
biochemically,  so  that  in  biochemical  experiments,  the 
weaker interaction is not detected. Consistent with this no- 
tion, a thrombic fragment of actin (residues 40-113), which 
contains most of the region identified genetically, has been 
found to be bound by filamin, albeit about two orders of  mag- 
nitude more weakly than other peptides derived from subdo- 
main 1 (Mtjean et al., 1992).  Of course, it may also be that 
the observed lower affinity of filamin for the actin thrombic 
peptide results from the inability of this peptide to refold af- 
ter purification (Mtjean et al., 1992),  that it has a different 
structure, or that the weak binding is not physiologically 
relevant. 
Evidence in favor of the notion that the conserved actin- 
binding domain binds to the sites on actin identified both ge- 
netically (this study and Holtzman et al.,  1994)  and bio- 
chemically (the previous  studies described above)  comes 
from the work of McGough et al. (1994).  In that study, an 
image reconstruction of the actin-binding domain of ~-acti- 
nin bound to filamentous actin is reported, and it presents 
evidence that the sites identified  by both the biochemical and 
genetic approaches may both be relevant (McGough et al., 
1994). Their analysis indicates that the actin-binding domain 
of ot-actinin is centered around subdomain 2 and makes con- 
tacts with subdomain 1 of the same actin monomer, as well 
as subdomain  1 of the adjacent actin monomer along the 
long-pitch strand (McGough et al., 1994).  Similar multido- 
main interactions have been observed for other actin-binding 
proteins. For example, the myosin subfragment 1 has been 
modeled as making contacts not only with subdomaln 1, but 
also with subdomain 2 of actin (Rayment et al.,  1993). 
In  summary, our results  and those of Holtzman et al. 
(1994)  identify a  likely  binding  site  on  actin  for  yeast 
fimbrin.  By comparison to the  structural analysis of the 
actin-binding domain of c~-actinin  by McGough et al. (1994), 
it would seem reasonable to expect that fimbrin, ~actinin, 
and the other actin cross-linking proteins that share the con- 
served actin-binding domain may all bind to the same region 
of actin. However,  even if these different proteins do share 
a common actin binding site, it remains to be seen whether 
there are additional contacts that serve to differentiate the in- 
teraction of these proteins with actin. In support of this no- 
tion, it has been noted that there are differences between 
ct-actinin and filamin in the ionic strength dependence of 
their binding to actin, implying the existence of additional 
contacts that differentiate the two complexes (Lebart et al., 
1993,  1994). 
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